MAX
Laboratorios Farmaceuticos Rovi, S.A.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
5/10
|
33.01 | 33.22 | -0.63% | 25.96 | +27.18% |
| P/S |
|
6.24 | 3.74 | 66.91% |
|
|
| P/BV |
|
6.98 | 3.6 | 93.73% |
|
|
| P/FCF |
|
38.58 | 32.38 | 19.17% |
|
|
| Ev/Ebitda |
|
23.02 | 15.06 | 52.86% |
|
|
| Ev/S |
|
6.3 | 4.22 | 49.15% |
|
|
| Ev/FCF |
|
38.98 | 44.17 | -11.75% |
|
|
| E/P |
|
0.0303 | 0.98 | -96.92% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
8/10
|
27.37 | 24.25 | 12.87% | 28.52 | -4.01% |
| ROE |
|
21.14 | 15.08 | 40.14% |
|
|
| ROA |
|
14.7 | 7.69 | 91.21% |
|
|
| ROIC |
|
0 | 14.03 | -100% |
|
|
| ROS |
|
23.29 | 17.87 | 30.34% |
|
|
| ROCE |
|
25.5 | 18.12 | 40.76% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
9/10
|
0.72 | 2.57 | -72.04% | 0.48 | +50.64% |
| Nеt Debt/Ebitda |
|
0.24 | -0.21 | -212.47% |
|
|
| Debt/Ratio |
|
0.15 | 0.22 | -30.25% |
|
|
| Debt/Equity |
|
0.22 | 1.01 | -78.21% |
|
|
| Debt/Net Income |
|
1.04 | 8.39 | -87.6% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
6.83/10
|
2.73 | 1.66 | 64.87% | 302.62 | -99.1% |
| Number of years of dividend growth |
|
4 | 1.47 | 172.57% | ||
| DSI |
|
0.92 | 0.77 | 19.52% |
|
|
| Average dividend growth |
|
20.15 | -65.19 | -130.92% |
|
|
| Average percentage for 5 years |
|
302.62 | 3.14 | 9534.19% |
|
|
| Average percentage for payments |
|
34.07 | 139.38 | -75.55% |
|
|
| Difference from average difference in sector |
|
1.07 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
4/10
|
20.71 | 50.71 | -59.16% | ||
| Growth impulse Ebitda in 5 years |
|
5.74 | 69.28 | -91.71% | ||
| Growth impulse Net Income in 5 years |
|
-3.38 | 49.86 | -106.78% | ||
| Growth impulse FCF in 5 years |
|
16.62 | 29.92 | -44.45% | ||
| Growth impulse EPS in 5 years |
|
4.77 | 86.88 | -94.51% |
IP Score
5.88/10
